Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
Tang M, Garg A, Bonate PL, Rosenberg JE, Matsangou M, Kadokura T, Yamada A, Choules M, Pavese J, Nagata M, Tenmizu D, Koibuchi A, Heo N, Wang L, Wojtkowski T, Hanley WD, Poondru S. Tang M, et al. Among authors: choules m. Clin Pharmacokinet. 2024 Apr;63(4):423-438. doi: 10.1007/s40262-024-01369-0. Epub 2024 Apr 12. Clin Pharmacokinet. 2024. PMID: 38609704 Free PMC article. Review.
International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.
Pruimboom-Brees IM, Gupta S, Chemuturi N, Booler HS, Nimz E, Ferrell Ramos M, Caruso A, Maass KF, Bantseev V, Huang Q, Choules MP, Nussbaum JC, Kanodia J, Thompson C, Durairaj C. Pruimboom-Brees IM, et al. Among authors: choules mp. Clin Transl Sci. 2023 May;16(5):723-741. doi: 10.1111/cts.13480. Epub 2023 Feb 2. Clin Transl Sci. 2023. PMID: 36651217 Free PMC article.
NMR reveals an undeclared constituent in custom synthetic peptides.
Choules MP, Bisson J, Simmler C, McAlpine JB, Giancaspro G, Bzhelyansky A, Niemitz M, Pauli GF. Choules MP, et al. J Pharm Biomed Anal. 2020 Jan 30;178:112915. doi: 10.1016/j.jpba.2019.112915. Epub 2019 Oct 10. J Pharm Biomed Anal. 2020. PMID: 31671336 Free PMC article.
Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.
Grzelak EM, Choules MP, Gao W, Cai G, Wan B, Wang Y, McAlpine JB, Cheng J, Jin Y, Lee H, Suh JW, Pauli GF, Franzblau SG, Jaki BU, Cho S. Grzelak EM, et al. Among authors: choules mp. J Antibiot (Tokyo). 2019 Oct;72(10):719-728. doi: 10.1038/s41429-019-0205-9. Epub 2019 Jul 11. J Antibiot (Tokyo). 2019. PMID: 31292530 Free PMC article. Review.
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
Wolf NM, Lee H, Choules MP, Pauli GF, Phansalkar R, Anderson JR, Gao W, Ren J, Santarsiero BD, Lee H, Cheng J, Jin YY, Ho NA, Duc NM, Suh JW, Abad-Zapatero C, Cho S. Wolf NM, et al. Among authors: choules mp. ACS Infect Dis. 2019 Jun 14;5(6):829-840. doi: 10.1021/acsinfecdis.8b00276. Epub 2019 May 3. ACS Infect Dis. 2019. PMID: 30990022 Free PMC article.
Quality Control of Therapeutic Peptides by 1H NMR HiFSA Sequencing.
Choules MP, Bisson J, Gao W, Lankin DC, McAlpine JB, Niemitz M, Jaki BU, Franzblau SG, Pauli GF. Choules MP, et al. J Org Chem. 2019 Mar 15;84(6):3055-3073. doi: 10.1021/acs.joc.8b02704. Epub 2019 Feb 22. J Org Chem. 2019. PMID: 30793905 Free PMC article.
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin YY, Cheng J, Lee H, Suh JW, Duc NM, Paik S, Choe JH, Jo EK, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S. Choules MP, et al. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02204-18. doi: 10.1128/AAC.02204-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30602512 Free PMC article.
14 results